Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

IFx-Hu2.0 Expanded Access Program

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04853602
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:17.645293+00:00
Published At
2024-08-12T00:00:00+00:00
Record Updated At
2024-08-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Cutaneous Melanoma, Stage III", "Cutaneous Melanoma, Stage IV", "Merkel Cell Carcinoma", "Cutaneous Squamous Cell Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-08-12"
protocolSection.identificationModule.nctId
"NCT04853602"
protocolSection.identificationModule.officialTitle
"IFx-Hu2.0 Expanded Access Program"
protocolSection.statusModule.overallStatus
"AVAILABLE"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Cutaneous Melanoma, Stage III (protocolSection.conditionsModule.conditions)
  • Cutaneous Melanoma, Stage IV (protocolSection.conditionsModule.conditions)
  • Merkel Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Cutaneous Squamous Cell Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.